NCT01582958

Brief Summary

This project proposes to test the hypothesis that osteopathic manipulative treatment (OMT) given to patients with moderate to severe chronic obstructive pulmonary disease (COPD) enrolled in a 12-week pulmonary rehabilitation program (PRP) will result in improved respiratory pump function over and above that seen in sham and control groups. Specifically, we will study the effects of three OMT techniques: (a) thoracic inlet indirect myofascial release; (b) rib raising with continued stretch of the paraspinal muscle to the L2 level; and (c) cervical paraspinal muscle stretch with suboccipital muscle release. The key clinical readouts will include: spirometry, P100 (and index of diaphragm and inspiratory muscle efficiency), maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP), as well as laser evaluation of chest wall excursion. Supplementing these objective parameters will be several more subjective clinical outcome measures: exercise tolerance (6-minute walk test), dyspnea (shortness of breath questionnaire), and quality of life questionnaire. Finally, an attempt will be made to correlate biochemical alterations that may shed light on the biological mechanism underlying the OMT procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Apr 2013

Typical duration for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2012

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 23, 2012

Completed
11 months until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

October 8, 2015

Status Verified

October 1, 2015

Enrollment Period

2.3 years

First QC Date

April 14, 2012

Last Update Submit

October 6, 2015

Conditions

Keywords

Osteopathic Manipulative TreatmentPulmonary Function TestsBiochemical Alterations

Outcome Measures

Primary Outcomes (4)

  • Change from baseline in spirometry at 6 weeks and 12 weeks

    amount (volume) and/or speed (flow) of air that can be inhaled and exhaled

    baseline, 6 weeks, 12 weeks

  • Change from baseline in P100 at 6 weeks and 12 weeks

    an index of diaphragm and inspiratory muscle efficiency (endurance)

    baseline, 6 weeks, 12 weeks

  • Change from baseline in MIP (maximum inspiratory pressure) and MEP (maximum expiratory pressure)at 6 weeks and 12 weeks.

    assessments of inspiratory and expiratory muscle function, respectively

    baseline, 6 weeks, 12 weeks

  • Change from baseline in inspiratory capacity at 6 weeks and 12 weeks.

    representing an indirect evaluation of chest wall excursion

    baseline, 6 weeks, 12 weeks

Secondary Outcomes (5)

  • Change from baseline in exercise tolerance at 6 weeks and 12 weeks.

    baseline, 6 weeks, 12 weeks

  • Change from baseline in dyspnea (shortness of breath) at 6 weeks and 12 weeks.

    baseline, 6 weeks, 12 weeks

  • Change from baseline in quality of life at 6 weeks and 12 weeks.

    baseline, 6 weeks, 12 weeks

  • Change from baseline in profiling of the plasma metabolome at 6 weeks and 12 weeks.

    baseline, 6 weeks, 12 weeks

  • Change from baseline in profiling of plasma proteins at 6weeks and 12 weeks.

    baseline, 6 weeks, 12 weeks

Study Arms (3)

Treatment

EXPERIMENTAL

This arm will receive the usual Pulmonary Rehabilitation Program plus OMT, the intervention.

Procedure: Osteopathic Manipulative Treatment (OMT)

placebo

PLACEBO COMPARATOR

Receives normal pulmonary rehabilitation care plus positioned to receive OMT but OMT is not provided.

Other: sham omt

Control

NO INTERVENTION

This arm receives only pulmonary rehabilitation care.

Interventions

Osteopathic Manipulative Treatment (OMT) is the therapeutic application of manually guided forces by an Osteopathic physician to improve physiologic function.

Also known as: Other names are not applicable.
Treatment

Hands are placed on subjects the same as omt arm but no omt is provided.

Also known as: Other names are not applicable.
placebo

Eligibility Criteria

Age49 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • postbronchodilator FEV1/FVC \<0.7 and FEV1 \<80% predicted \[FEV1 =volume that has been exhaled at the end of the first second of forced expiration\] and FVC volume of air that can be forcibly blown out after full inspiration\]
  • history of smoking \>20 pack-years
  • optimal medical therapy for at least eight weeks with no change

You may not qualify if:

  • history of active pulmonary disease such as asthma
  • positive bronchodilator test
  • treatment with N-acetylcysteine
  • previous diagnosis of hypertension or current anti-hypertensive treatment
  • known unstable or moderate to severe heart disease (arrhythmia, ischemic heart disease, or cardiomyopathy)
  • previous diagnosis of chronic illness such as diabetes, renal failure, hypercholesterolemia, hepatic cirrhosis, cancer, rheumatoid arthritis or any other systemic inflammatory disease
  • neuromuscular or disabling cognitive problems
  • engagement in any exercise-training program during the past three months
  • substance abuse in the preceding six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McClaren Greater Lansing

Lansing, Michigan, 48910, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Sherman Gorbis, DO

    Michigan State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 14, 2012

First Posted

April 23, 2012

Study Start

April 1, 2013

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

October 8, 2015

Record last verified: 2015-10

Locations